期刊文献+

2010年度卫生部全国细菌耐药监测报告:非ICU住院感染患者细菌耐药监测 被引量:19

Mohnarin report 2010:surveillance of antimicrobial resistance of clinical isolates from Non-ICU inpatients
原文传递
导出
摘要 目的了解全国2010年非ICU住院患者临床分离细菌分布及耐药性。方法收集2010年1月1日-12月31日全国129所医院非ICU住院患者临床分离细菌药物敏感性试验数据,根据2010年美国临床实验室标准化研究所标准,用WHONET 5.6软件进行数据分析。结果共获得临床分离菌216 872株,其中革兰阴性菌152 351株,占70.2%;革兰阳性菌64 521株,占29.8%;最常见的细菌依次为大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌、鲍氏不动杆菌和金黄色葡萄球菌;耐甲氧西林金黄色葡萄球菌与凝固酶阴性葡萄球菌的检出率分别为52.1%、83.8%;未发现耐万古霉素葡萄球菌,粪肠球菌和屎肠球菌对万古霉素耐药率分别为0.6%和3.3%,未发现耐利奈唑胺肠球菌属;耐青霉素肺炎链球菌检出率为10.7%;有5.9%和1.8%大肠埃希菌及9.1%和3.5%肺炎克雷伯菌对亚胺培南和美罗培南耐药;铜绿假单胞菌对碳青霉烯类抗菌药物的耐药率约为20.0%,鲍氏不动杆菌耐药率超过铜绿假单胞菌。结论我国非ICU住院患者感染致病细菌耐药现象仍较为普遍,但同上年度相比,多数细菌耐药率未呈上升趋势。 OBJECTIVE To investigate the bacterial distribution and antimicrobial resistance of clinical isolates from non-ICU inpatients in China. METHODS The data of drug susceptibility testing of clinical isolates from non-ICU inpatients in 1-9 hospitals form Jan 1 to Dec 31, 2010 were collected. The susceptibilities of isolates to antimicrobial agents were determined by CLSI 2010 guideline and the data were analyzed by WHONET 5. 6 software. RESULTS A total of 216 872 clinical isolates were obtained, which included 152 315 (70.2%) gramnegative bacterial isolates and 64 521 (29. 8%) gram-positive bacteria isolates. Escheichia coli, Pseudomonas aeroginosa, Klebsiella pneurnoniae,Acinetobacter baumannii and Staphylococcus aureus were the most common isolates. The detection rates of methiciIlin-resistant S. aureus (MRSA) and coagulase-negative Staphylococcus (MRSCNS) were 52.1% and 83.8%, respectively; No vancomycin-resistant Staphylococcus strains were found, the resistance rates of E. faecalis and Enterococcus faecium to vancomyein were 0.6% and 3.3 %, respectively. No linezolid-resistant Enterococcus isolates were found; the detection rate of penicillin-resistant Streptococcus pneumoniae (PRSP) was 10.7% ; there were 5.9% and 1.8% of E. coli as well as 9.1% and 3.5% of K. pneumoniae isolates resistant to imipenem and meropenem. The resistance rate of P. aeruginosa to carbapenems was 20.0% ,while the drug resistance rate of A. baumannii was higher than that of P. aeruginosa. CONCLUSION Drug resistance of pathogenic bacteria from nonqCU inpatients is universal in China, but compared with that of last year, the drug resistance rate of most isolates does not present an upward trend.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第1期28-33,共6页 Chinese Journal of Nosocomiology
关键词 卫生部全国细菌耐药监测 非ICU 住院患者 细菌 耐药性 Mohnarin Non-ICU Inpatients Bacterium Resistance
  • 相关文献

参考文献6

二级参考文献22

  • 1李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 2张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 3XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 4宁永忠,王辉,孙宏莉,朱任媛,刘振英,张捷.大肠埃希菌和肺炎克雷伯菌产生的超广谱β-内酰胺酶和质粒AmpC型β-内酰胺酶的分子流行病学研究[J].中华微生物学和免疫学杂志,2006,26(10):944-949. 被引量:35
  • 5McGowan JE. Resistance in nonfermenting gram - negative bacteria: multidrug resistance to the maximum [ J ]. Associat Profess Infect Control Epidemiol, 2006; 34( Suppl. 1 ) : S29 -S37.
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Wayne: Clinical and Laboratory Standards Institute, 2009.
  • 7Turmer PJ. MYSTIC Europe 2007 : activity of meropenem and other broad - spectrum agents against nosocomial isolates [ J ]. Diag Microb Infect Dis ,2009 ; 63 : 217 - 222.
  • 8Bouchillon SK, Iredell JR, Barkham T, et al. Comparative in vitro activity of tigecycline and other antimicrobials against Gram - negative and Gram - positive organisms collected from the Asia - Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST) [J]. Int JAntimicrob Agents, 2009; 33:130 -136.
  • 9Yau W, Owen RJ, Poudyal A, et al. Colistin hetero - resistance in muhidrug - resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme [ J ]. J Infect,2009 ;58 : 138 - 144.
  • 10Koomanachai P, Crandon JL, Kuti JL, et al. Comparative phannacodynamics for intravenous antibiotics against gram - negative bacteria in Europe between 2002 and 2006 : a report from the OPTAMA program[ J]. Int J Antimicrob Agents, 2009 ; 33 : 348 - 353.

共引文献621

同被引文献113

引证文献19

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部